VCM
MRNA icon

Voleon Capital Management’s Moderna MRNA Stock Holding History

Voleon Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Sell
13,181
-8,828
-40% -$412K 0.01% 518
2025
Q4 		$649K Buy
22,009
+11,891
+118% +$323K 0.01% 524
2025
Q3 		$261K Buy
+10,118
New +$282K 0.01% 762
2025
Q2 		– Sell
-42,507
Closed -$1.21M – 509
2025
Q1 		$1.21M Buy
+42,507
New +$1.51M 0.09% 180

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voleon Capital Management's MRNA Position: Q1 2026 in Review

Voleon Capital Management reduced its Moderna (MRNA) stake by 40% in Q1 2026, selling an estimated $412K and leaving 13,181 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #518.

Voleon Capital Management first reported a position in MRNA in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.21M in Q1 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Voleon Capital Management held 13,181 shares of Moderna worth $670K as of Q1 2026.
  • Voleon Capital Management sold 8,828 Moderna shares in Q1 2026, an estimated $412K.
  • Moderna made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #518 holding.
  • Voleon Capital Management first reported a position in Moderna in Q1 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Moderna position peaked at $1.21M in Q1 2025.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.